低分子肝素预防膝关节镜手术与前交叉韧带重建患者静脉血栓栓塞症:随机对照试验的荟萃分析
该荟萃分析纳入8项随机对照试验共4113例患者,评估低分子肝素(LMWH)预防膝关节镜手术及前交叉韧带重建(ACLR)后静脉血栓栓塞症(VTE)的疗效与安全性。结果显示,单纯膝关节镜手术患者使用LMWH未显著降低主要VTE和全部VTE风险,但增加全部出血事件风险;ACLR患者使用LMWH显著降低主要VTE和全部VTE风险,且未增加出血事件风险。
要点
- 单纯膝关节镜手术患者:LMWH未显著降低主要VTE(RR 1.00)和全部VTE(RR 0.63),但全部出血事件风险升高(RR 1.64)。
- ACLR患者:LMWH显著降低主要VTE(RR 0.23)和全部VTE(RR 0.22),主要出血事件和全部出血事件风险未增加。
- 共纳入8项随机对照试验、4113例患者,按单纯膝关节镜手术和ACLR分为2个亚组。
核心结论
- 与未使用LMWH相比,LMWH在单纯膝关节镜手术患者中预防VTE无显著疗效,但增加出血事件风险。
- 与未使用LMWH相比,LMWH在主要接受ACLR的患者中预防VTE有显著疗效,且不增加出血事件风险。
研究设计与样本
- 研究设计为荟萃分析,检索MEDLINE、Embase、Cochrane CENTRAL、ClinicalTrials.gov和Web of Science从建库至2017年6月30日的随机对照试验。
- 共纳入8项随机对照试验、4113例患者,分为单纯膝关节镜手术和ACLR两个亚组。
- 主要疗效终点为主要VTE发生率,主要安全终点为主要出血事件发生率;次要终点为全部VTE和全部出血事件发生率。
- 使用Review Manager 5.3计算相对危险度(RR)及95%CI。
主要发现
- 单纯膝关节镜手术患者:LMWH组与未使用LMWH组相比,主要VTE风险无显著差异(RR 1.00,95%CI 0.37-2.67,P > .99),全部VTE风险无显著差异(RR 0.63,95%CI 0.31-1.29,P = .21)。
- 单纯膝关节镜手术患者:LMWH组主要出血事件风险无显著差异(RR 0.98,95%CI 0.06-15.72,P = .99),但全部出血事件风险升高(RR 1.64,95%CI 1.18-2.28,P = .003)。
- ACLR患者:LMWH组主要VTE风险显著降低(RR 0.23,95%CI 0.12-0.43,P < .001),全部VTE风险显著降低(RR 0.22,95%CI 0.06-0.73,P = .01)。
- ACLR患者:LMWH组主要出血事件风险无显著差异(RR 1.80,95%CI 0.19-17.25,P = .61),全部出血事件风险无显著差异(RR 1.12,95%CI 0.72-1.74,P = .61)。
关键数值与推荐
- 单纯膝关节镜手术患者:LMWH组主要VTE的RR为1.00(95%CI 0.37-2.67,P > .99),全部VTE的RR为0.63(95%CI 0.31-1.29,P = .21)。
- 单纯膝关节镜手术患者:LMWH组主要出血事件的RR为0.98(95%CI 0.06-15.72,P = .99),全部出血事件的RR为1.64(95%CI 1.18-2.28,P = .003)。
- ACLR患者:LMWH组主要VTE的RR为0.23(95%CI 0.12-0.43,P < .001),全部VTE的RR为0.22(95%CI 0.06-0.73,P = .01)。
- ACLR患者:LMWH组主要出血事件的RR为1.80(95%CI 0.19-17.25,P = .61),全部出血事件的RR为1.12(95%CI 0.72-1.74,P = .61)。
临床怎么用
- 对于单纯膝关节镜手术患者,与未使用LMWH相比,LMWH预防未显著降低VTE风险,且全部出血事件风险升高。
- 对于主要接受ACLR的患者,与未使用LMWH相比,LMWH预防显著降低VTE风险,且未增加出血事件风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low-molecular-weight heparin (LMWH) thromboprophylaxis is widely used for reducing the risk of thrombosis after major orthopaedic surgery. However, the effect and safety on knee arthroscopic surgery are still controversial. PURPOSE: To assess the efficacy and safety of LMWH for the prevention of symptomatic venous thromboembolism (VTE) after knee arthroscopic surgery and anterior cruciate ligament reconstruction (ACLR) by conducting a meta-analysis of randomized controlled trials (RCTs). STUDY DESIGN: Meta-analysis. METHODS: The authors searched the electronic databases of MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), ClinicalTrials.gov , and Web of Science for all studies from inception to June 30, 2017. All selected studies were categorized into 2 subgroups: simple knee arthroscopic surgery and ACLR. The primary effect and safety endpoint were the incidence of major VTE and major bleeding events (BEs), respectively. The secondary effect and safety endpoint were the incidence of all VTE and all BEs, respectively. Relative risks (RRs) with 95% CIs were calculated using Review Manager 5.3. RESULTS: Eight RCTs with 4113 patients were included. For patients undergoing simple knee arthroscopic surgery, LMWH prophylaxis did not bring a significant reduction in the risk of major VTE (RR, 1.00 [95% CI, 0.37-2.67]; P > .99) and all VTE (RR, 0.63 [95% CI, 0.31-1.29]; P = .21) and did not increase the risk of major BEs (RR, 0.98 [95% CI, 0.06-15.72]; P = .99) but did have a higher risk of all BEs (RR, 1.64 [95% CI, 1.18-2.28]; P = .003) in comparison with non-LMWH prophylaxis. For patients undergoing ACLR, LMWH prophylaxis was associated with a significantly lower rate of major VTE (RR, 0.23 [95% CI, 0.12-0.43]; P < .001) and all VTE (RR, 0.22 [95% CI, 0.06-0.73]; P = .01) but no increase in major BEs (RR, 1.80 [95% CI, 0.19-17.25]; P = .61) and all BEs (RR, 1.12 [95% CI, 0.72-1.74]; P = .61) in comparison with non-LMWH prophylaxis. CONCLUSION: Compared with non-LMWH treatment, LMWH had no significant efficacy in preventing VTE in patients undergoing simple knee arthroscopic surgery but increased the risk of BEs. However, LMWH had significant efficacy in preventing VTE for patients mainly undergoing ACLR and did not increase the risk of BEs.
引用
- Zhu J, Jiang H, Marshall B, et al. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2018. PMID: 30113231. doi:10.1177/0363546518782705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。